• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

HEROES program awarded more than $2 million to continue opioid intervention outreach in Houston

Bioengineer by Bioengineer
February 5, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Photo by Maricruz Kwon/UTHealth


The Houston Emergency Response Opioid Engagement System (HEROES) was recently awarded two grants that will help fund the opioid intervention program through the end of 2020. James Langabeer, PhD, MBA, a professor at The University of Texas Health Science Center at Houston (UTHealth), created the program to provide comprehensive treatment for opioid abusers, gain a more thorough understanding of the epidemic in Houston, and work toward getting the highly addictive drugs off the streets.

Based on the program’s success since its inception in the spring of 2018, HEROES was granted $1.85 million from the Texas Health and Human Services Commission (HHS) to continue its mission. HHS received the funding from the Substance Abuse and Mental Health Services Administration, a federal agency, to allocate for state opioid response grants. HEROES was also awarded $350,000 from the U.S. Department of Justice.

According to research gathered through the program, Harris County sees about 150 opioid-related overdoses every month, resulting in an average of 20-25 deaths.

“The opioid epidemic in Houston is more grave than many would like to admit,” said Langabeer. “HEROES allows us to collect meaningful data to understand the scope of the problem, while also practicing what we call ‘assertive outreach’ to offer a solution for people struggling with addiction. The opioid crisis does not discriminate – we see people of all ages, races, and ZIP codes, and we’re able to offer them a tangible way to get help.”

The HEROES program is a joint initiative between the School of Biomedical Informatics and McGovern Medical School at UTHealth, which partners with the Houston Fire Department, Houston Police Department, and Memorial Hermann-Texas Medical Center. Overdose data from Harris County is used to guide a quick-response team, including a paramedic and recovery coach, who knocks on doors and offers people who have just recovered from an overdose the opportunity to enroll in a comprehensive treatment program at no cost to them.

“Most people struggling with an opioid addiction fight it alone, and will not proactively seek help. We remove that barrier by bringing help to them, and for many it is the first time they’ve been presented with a feasible option to seek recovery,” said Langabeer.

Currently, there are nearly 150 patients in the clinical trial, and about 75 percent of them have been drug-free and remained engaged in treatment for more than 30 days. Treatment through the HEROES program includes access to opioid overdose reversal medication, a 24/7 recovery coach, behavioral counseling with an addiction counselor, weekly support groups, help connecting to county resources, and more.

The new funding will help the program grow its staff and network of partners to further combat the opioid epidemic.

“We intend to expand our reach and offer comprehensive services to a larger patient base across Southeast Texas,” said Langabeer. “The team is considering implementing a variety of new services as well, including a recovery mobile app to help improve our communication with patients. We also hope to use the data we’ve collected to improve health policy across the state and nation related to drug use and addiction.”

###

For more information or to enroll in the HEROES program, email [email protected] or call 713-500-3597.

About UTHealth

Established in 1972 by The University of Texas System Board of Regents, The University of Texas Health Science Center at Houston (UTHealth) is Houston’s Health University and Texas’ resource for health care education, innovation, scientific discovery and excellence in patient care. The most comprehensive academic health center in the UT System and the U.S. Gulf Coast region, UTHealth is home to Jane and Robert Cizik School of Nursing, John P. and Kathrine G. McGovern Medical School, and schools of biomedical informatics, biomedical sciences, dentistry, and public health. UTHealth includes The University of Texas Harris County Psychiatric Center, as well as the growing clinical practices UT Physicians, UT Dentists, and UT Health Services. The university’s primary teaching hospitals are Memorial Hermann-Texas Medical Center, Children’s Memorial Hermann Hospital, and Harris Health Lyndon B. Johnson Hospital. For more information, visit http://www.uth.edu.

Media Contact
Amy Laukka
[email protected]
980-622-6264

Original Source

http://uth.edu/news/story.htm?id=5250c36c-f0d1-4c9c-be7e-795b39fac5e6

Tags: AddictionClinical TrialsMedicine/Health
Share12Tweet7Share2ShareShareShare1

Related Posts

Advancing Pediatric TB Diagnostics in Endemic Regions

August 26, 2025

Uninsured Patients Face Reduced Access to Life-Saving Hospital Transfers

August 26, 2025

American Gastroenterological Association and Latica Collaborate to Evaluate Living Guidelines Through Real-World Evidence

August 26, 2025

New Strategies for Enhancing GLP-1 Oral Absorption

August 26, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    148 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Advancing Pediatric TB Diagnostics in Endemic Regions

Uninsured Patients Face Reduced Access to Life-Saving Hospital Transfers

Immune Cells in the Brain: Crucial Architects of Adolescent Neural Wiring

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.